Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥20.2bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥36.2bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥18.1bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥2.5bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥1.5bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥2.4bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥1.7bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.3bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥2.4bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥2.3bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.2bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.1bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥1.9bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥2.1bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥84.4bnat 2024-09-30Cons.Assets
Total assets¥81.8bnat 2024-03-31Cons.Assets
Total assets¥79.6bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥9.1bnat 2024-09-30Cons.Liabilities
Total liabilities¥9.5bnat 2024-03-31Cons.Liabilities
Net assets / equity¥75.3bnat 2024-09-30Cons.Net assets
Net assets / equity¥72.3bnat 2024-03-31Cons.Net assets
Net assets / equity¥71.5bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥16.9bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥15.4bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥19.8bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥18.7bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥21.0bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥25.8bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥3.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥513m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥490m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥7.2bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥732m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.5bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥731m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥35.392024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥40.082023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.542023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio89.2%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio88.4%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio89.9%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue2024-04-01 → 2024-09-30¥5.9bn
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue external2024-04-01 → 2024-09-30¥5.9bn
jpcrp040300-q2r_E00970-000LALreportable segmentsegment profit2024-04-01 → 2024-09-30¥481m
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue2024-04-01 → 2024-09-30¥14.3bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue external2024-04-01 → 2024-09-30¥14.3bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentsegment profit2024-04-01 → 2024-09-30¥2.1bn
—segment totalrevenue2024-04-01 → 2024-09-30¥20.2bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥20.2bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥2.5bn
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue2023-04-01 → 2023-09-30¥5.0bn
jpcrp040300-q2r_E00970-000LALreportable segmentrevenue external2023-04-01 → 2023-09-30¥5.0bn
jpcrp040300-q2r_E00970-000LALreportable segmentsegment profit2023-04-01 → 2023-09-30¥420m
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue2023-04-01 → 2023-09-30¥13.1bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentrevenue external2023-04-01 → 2023-09-30¥13.1bn
jpcrp040300-q2r_E00970-000Pharmaceuticalreportable segmentsegment profit2023-04-01 → 2023-09-30¥1.1bn
—segment totalrevenue2023-04-01 → 2023-09-30¥18.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥18.1bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 518
ItemContextValueUnit
Allowance for doubtful accounts ioa by groupPrior1YearInstant-7000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-7000000JPY
Investments and other assetsPrior1YearInstant21828000000JPY
Investments and other assetsCurrentQuarterInstant22328000000JPY
Noncurrent assetsPrior1YearInstant40248000000JPY
Noncurrent assetsCurrentQuarterInstant42930000000JPY
AssetsPrior1YearInstant81795000000JPY
AssetsCurrentQuarterInstant84360000000JPY
Accounts payable tradePrior1YearInstant1652000000JPY
Accounts payable tradeCurrentQuarterInstant1502000000JPY
Short term loans payablePrior1YearInstant300000000JPY
Short term loans payableCurrentQuarterInstant300000000JPY
Lease obligations clPrior1YearInstant35000000JPY
Lease obligations clCurrentQuarterInstant35000000JPY
Accounts payable otherPrior1YearInstant2851000000JPY
Accounts payable otherCurrentQuarterInstant2434000000JPY
Income taxes payablePrior1YearInstant113000000JPY
Income taxes payableCurrentQuarterInstant177000000JPY
Provision for bonusesPrior1YearInstant676000000JPY
Provision for bonusesCurrentQuarterInstant754000000JPY
Provision for environmental measures clPrior1YearInstant124000000JPY
Provision for environmental measures clCurrentQuarterInstant116000000JPY
Other clPrior1YearInstant1443000000JPY
Other clCurrentQuarterInstant1465000000JPY
Current liabilitiesPrior1YearInstant7198000000JPY
Current liabilitiesCurrentQuarterInstant6786000000JPY
Lease obligations nclPrior1YearInstant61000000JPY
Lease obligations nclCurrentQuarterInstant53000000JPY
Deferred tax liabilitiesPrior1YearInstant2108000000JPY
Deferred tax liabilitiesCurrentQuarterInstant2085000000JPY
Asset retirement obligations nclPrior1YearInstant37000000JPY
Asset retirement obligations nclCurrentQuarterInstant37000000JPY
Other nclPrior1YearInstant106000000JPY
Other nclCurrentQuarterInstant106000000JPY
Noncurrent liabilitiesPrior1YearInstant2313000000JPY
Noncurrent liabilitiesCurrentQuarterInstant2284000000JPY
LiabilitiesPrior1YearInstant9512000000JPY
LiabilitiesCurrentQuarterInstant9070000000JPY
Capital stockPrior1YearInstant3840000000JPY
Capital stockCurrentQuarterInstant3840000000JPY
Capital surplusPrior1YearInstant5301000000JPY
Capital surplusCurrentQuarterInstant5301000000JPY
Retained earningsPrior1YearInstant54738000000JPY
Retained earningsCurrentQuarterInstant55958000000JPY
Treasury stockPrior1YearInstant-2259000000JPY
Treasury stockCurrentQuarterInstant-2242000000JPY
Shareholders equityPrior1YearInstant61620000000JPY
Shareholders equityCurrentQuarterInstant62857000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant5526000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant5291000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass